CryoLife, Inc. (NYSE:CRY)

CAPS Rating: 5 out of 5

The Company develops and commercializes biomaterials, implantable medical devices, and preserves and distributes human tissues for cardiovascular and vascular transplant applications.

Recs

0
Player Avatar Fiskhus (72.87) Submitted: 11/18/2011 11:04:50 AM : Outperform Start Price: $4.57 CRY Score: -7.13

recycle -30

Featured Broker Partners


Advertisement